Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Share News (INF)

Share Price Information for Informa (INF)

Share Price is delayed by 15 minutes
Get Live Data
844.20    28.00 (3.43%)
Bid:
838.00
Ask:
838.80
Spread: 0.80 (0.095%)
Market Cap: £10.61b
INF Live PriceLast checked at - London Stock Exchange

Intraday Informa Share Chart

Informa optimistic after solid 2023

Thu, 11th Jan 2024 07:23

(Sharecast News) - Events, digital services and business information specialist Informa reported a robust 2023 performance in a trading update on Thursday, alongside optimism over further growth in 2024.

The company said it expected to achieve a 2023 underlying revenue growth of about 30%, with reported revenue of over £3.17bn, adjusted operating profit of around £845m, and free cash flow of over £600m.

For 2024, Informa anticipated high single-digit underlying revenue growth, with reported revenue projected to be between £3.43bn and £3.48bn, and adjusted operating profit expected to range from £945m to £965m.

The company's strong performance was leading to improving shareholder returns, with a significant portion of the current share buyback programme completed by year-end and a substantial increase in the 2023 dividend.

Informa said its B2B digital services were also set to experience accelerated growth following the announcement of the combination of Informa Tech's digital businesses with US-based TechTarget, which was expected to elevate annual B2B revenues to around £3bn after completion in the second half of 2024.

Additionally, the company expected continued growth in its academic markets, with an underlying revenue growth target of approximately 4% for 2024.

Informa said its positive outlook was underpinned by its strong position in live and on-demand B2B events, specialist knowledge, and high-growth B2B markets such as pharma, healthcare, technology, health and nutrition, beauty, and aviation, as well as its international reach and solid balance sheet.

"Informa delivered a standout performance in 2023 and we are committing to further strong growth in 2024," said group chief executive officer Stephen Carter.

At 0852 GMT, shares in Informa were down 2.11% at 768.6p.

Reporting by Josh White for Sharecast.com.

Related News

LONDON BROKER RATINGS: Exane raises Spirax, UBS cuts Fermi
6 May 2026

LONDON BROKER RATINGS: Exane raises Spirax, UBS cuts Fermi

(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday:

Informa News

LONDON BROKER RATINGS: Kenmare Resources raised to 'buy' after bid approach
7 Mar 2025

LONDON BROKER RATINGS: Kenmare Resources raised to 'buy' after bid approach

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

Informa sees more growth in 2025, will partner Dubai World Trade Centre
6 Mar 2025

Informa sees more growth in 2025, will partner Dubai World Trade Centre

March 6 (Reuters) - Informa, a British events and academic publishing group, said on Thursday 2025 would be another year of double-digit percentage...

Informa lifts dividend as adjusted profit up; targets revenue growth
6 Mar 2025

Informa lifts dividend as adjusted profit up; targets revenue growth

(Alliance News) - Informa PLC on Thursday said it expects to grow revenue further, as it celebrated an "outstanding" 2024.

Dubai's DWTC and Informa create exhibitions, event management joint venture
6 Mar 2025

Dubai's DWTC and Informa create exhibitions, event management joint venture

DUBAI, March 6 (Reuters) - Dubai World Trade Centre is forming a joint venture with Informa, the world's largest exhibition group, to pursue opportu...

Informa reports solid year as it pivots to more profitable markets
6 Mar 2025

Informa reports solid year as it pivots to more profitable markets

(Sharecast News) - Informa reported a solid set of financial results for 2024 on Thursday, delivering double-digit revenue and profit growth alongside...

LONDON BROKER RATINGS: UBS raises AstraZeneca to 'buy'
13 Feb 2025

LONDON BROKER RATINGS: UBS raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:

LONDON BROKER RATINGS: Barclays raises Intertek; HSBC raises Greggs
24 Jan 2025

LONDON BROKER RATINGS: Barclays raises Intertek; HSBC raises Greggs

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: